Assessment of the acceptability of testing and treatment during a mass drug administration trial for malaria in Zambia using mixed methods

American Journal of Tropical Medicine and Hygiene

Volumn 103, Issue 2, 2020, Pages 28-36

  Silumbe, Kafula ^a   Finn, Timothy P ^b   Jennings, Todd ^a   Sikombe, Chilumba ^a   Chiyende, Elizabeth ^a   Hamainza, Busiku ^c   Kawesha, Elizabeth Chizema ^c   Eisele, Thomas P ^b   Earle, Duncan ^a   Steketee, Richard W ^a   Miller, John M ^a  

^a Malaria Control and Evaluation Partnership in Africa (MACEPA)   (Zambia)

^b TULANE UNIVERSITY   (United States)

^c MINISTRY OF HEALTH   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ADULT; ARTICLE; CATCHMENT AREA (HEALTH); CHILD; CLINICAL EFFECTIVENESS; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HOUSEHOLD; HUMAN; HUMAN EXPERIMENT; LIKERT SCALE; MALARIA; MALARIA CONTROL; MALE; MASS DRUG ADMINISTRATION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT REFUSAL; ZAMBIA; ATTITUDE TO HEALTH; COMBINATION DRUG THERAPY; DISEASE ERADICATION; INFORMATION PROCESSING; MALARIA FALCIPARUM; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY;

ADULT; ARTEMISININS; ATTITUDE TO HEALTH; DISEASE ERADICATION; DRUG THERAPY, COMBINATION; FEMALE; FOCUS GROUPS; HUMANS; MALARIA, FALCIPARUM; MALE; MASS DRUG ADMINISTRATION; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUINOLINES; ZAMBIA;

EID: 85089301902     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.19-0663     Document Type: Article

References (16)

1. Eisele TP et al., 2015. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial. Trials 16: 347.
2. Zambia Ministry of Health, 2016. National Malaria Indicatory Survey 2015. Lusaka, Zambia: Zambia Ministry of Health.
3. Zambia Ministry of Health, 2017. National Malaria Elimination Strategic Plan 2017-2021. Lusaka, Zambia: Zambia Ministry of Health.
4. Zambia Ministry of Health, 2014. Guidelines on Diagnosis and Treatment of Malaria in Zambia, 4th edition. Lusaka, Zambia: Zambia Ministry of Health.
5. Larsen DA, Bennett A, Silumbe K, Hamainza B, Yukich JO, Keating J, Littrell M, Miller JM, Steketee RW, Eisele TP, 2015. Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in Southern Zambia: a community randomized step-wedge control trial design. Am J Trop Med Hyg 92: 913-921.
6. Silumbe K et al., 2015. A qualitative study of perceptions of a mass test and treat campaign in Southern Zambia and potential barriers to effectiveness. Malar J 14: 480.
7. Okello G, Ndegwa SN, Halliday KE, Hanson K, Brooker SJ, Jones C, 2012. Local perceptions of intermittent screening and treatment for malaria in school children on the south coast of Kenya. Malar J 11: 185.
8. Okell L et al., 2015. Consensus Modelling Evidence to Support the Design of Mass Drug Administration Programmes. Geneva, Switzerland: Malaria Policy Advisory Committee.
9. Shuford K, Were F, Awino N, Samuels A, Ouma P, Kariuki S, Desai M, Allen DR, 2016. Community perceptions of mass screening and treatment for malaria in Siaya county, western Kenya. Malar J 15: 71.
10. Nguyen TN et al., 2017. Community perceptions of targeted antimalarial mass drug administrations in two provinces in Vietnam: a quantitative survey. Malar J 16: 17.
11. Dial NJ, Ceesay SJ, Gosling RD, D'Alessandro U, Baltzell KA, 2014. A qualitative study to assess community barriers to malaria mass drug administration trials in the Gambia. Malar J 13: 1-9.
12. Zambia Ministry of Health, 2015. Zambia National Malaria Indicator Survey 2015. Lusaka, Zambia: Zambia Ministry of Health.
13. Walker JL, 2012. The use of saturation in qualitative research. Can J Cardiovasc Nurs 22: 37-46.
14. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D, 2014. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev 1: 1-160.
15. Kajeechiwa L et al., 2016 The acceptability mass administrations of anti-malarial drug as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J 15: 494.
16. Eisele TP et al., 2020. Impact of four rounds of mass drug administration with dihydroartemisinin-piperaquine implemented in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 7-18.